COR-1, an Anti-Beta1 Receptor Antibody Cyclopeptide in Heart Failure: a Phase II, Multicentre, Randomised, Double-Blind and Placebo-Controlled Study With Parallel Groups.
Phase of Trial: Phase II
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Mibenratide (Primary)
- Indications Dilated cardiomyopathy; Heart failure
- Focus Therapeutic Use
- Sponsors Corimmun
- 10 Jun 2017 Biomarkers information updated
- 01 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Mar 2013 Planned End Date changed from 1 Sep 2013 to 1 Sep 2014 as reported by ClinicalTrials.gov.